Zhang Li-Ping, Zhang Zhen-Guo, Guan Jian, Li Li-Qun
Department of Plastic Surgery, Wenzhou Medical University Lishui Hospital, Lishui People' s Hospital, Lishui.
Department of Plastic Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Melanoma Res. 2025 Oct 1;35(5):306-316. doi: 10.1097/CMR.0000000000001055. Epub 2025 Jul 16.
To explore the functional role of thrombospondin 2 (THBS2) in the metastasis of skin cutaneous melanoma (SKCM), with a focus on its regulation of angiogenesis and extracellular matrix (ECM) remodeling. THBS2 expression was assessed in normal melanocytes and SKCM cell lines with varying metastatic potential. Functional analyses were conducted after THBS2 knockdown in A375 cells and overexpression in G-361 cells. Effects on migration, invasion, endothelial tube formation, and angiogenesis- and ECM-related factors were evaluated. Tumor IMmune Estimation Resource database was used for correlation analyses in SKCM samples. A liver metastasis model was established by intrasplenic injection of B16-F10 cells into Thbs2 knockout and wild-type mice, followed by quantification of hepatic metastases and molecular analysis of peritumoral liver tissue. THBS2 was highly expressed in invasive melanoma cell lines and was positively associated with VEGFA, PECAM1, and MMPs in both databases and experimental models. Knockdown of THBS2 significantly suppressed VEGFA, PECAM1, FGF2, FLT1, MMP2, MMP9, and ECM components (LAMA4, COL1A1, and COL4A1) at mRNA and protein levels, inhibited melanoma cell migration and invasion, and reduced tube formation in human umbilical vein endothelial cells. Overexpression had opposite effects. In vivo , Thbs2 knockout mice exhibited significantly fewer hepatic metastases and reduced metastatic area compared with wild-type controls. Expression of Lama4, Pecam1, Vegfa, Mmp2, and Mmp9 was markedly lower in peritumoral liver tissue of knockout mice. THBS2 promotes SKCM metastasis by enhancing angiogenesis and ECM remodeling. Targeting THBS2 may represent a promising strategy for inhibiting melanoma progression and distant organ colonization.
为了探究血小板反应蛋白2(THBS2)在皮肤黑色素瘤(SKCM)转移中的功能作用,重点关注其对血管生成和细胞外基质(ECM)重塑的调节。在具有不同转移潜能的正常黑素细胞和SKCM细胞系中评估了THBS2的表达。在A375细胞中敲低THBS2并在G - 361细胞中过表达后进行功能分析。评估了对迁移、侵袭、内皮管形成以及血管生成和ECM相关因子的影响。使用肿瘤免疫评估资源数据库对SKCM样本进行相关性分析。通过将B16 - F10细胞脾内注射到Thbs2基因敲除小鼠和野生型小鼠中建立肝转移模型,随后对肝转移进行定量并对肿瘤周围肝组织进行分子分析。THBS2在侵袭性黑色素瘤细胞系中高表达,并且在数据库和实验模型中均与VEGFA、PECAM1和基质金属蛋白酶呈正相关。敲低THBS2在mRNA和蛋白质水平上显著抑制VEGFA、PECAM1、FGF2、FLT1、MMP2、MMP9和ECM成分(LAMA4、COL1A1和COL4A1),抑制黑色素瘤细胞迁移和侵袭,并减少人脐静脉内皮细胞中的管形成。过表达则产生相反的效果。在体内,与野生型对照相比,Thbs2基因敲除小鼠的肝转移明显减少,转移面积减小。敲除小鼠肿瘤周围肝组织中Lama4、Pecam1、Vegfa、Mmp2和Mmp9的表达明显较低。THBS2通过增强血管生成和ECM重塑促进SKCM转移。靶向THBS2可能是抑制黑色素瘤进展和远处器官定植的一种有前景的策略。
Biochem Biophys Res Commun. 2025-5-29
Nan Fang Yi Ke Da Xue Xue Bao. 2025-7-20
Cochrane Database Syst Rev. 2018-2-6
Cancers (Basel). 2024-1-19
JAMA Dermatol. 2022-5-1